Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2011 (2011), Article ID 827693, 6 pages
http://dx.doi.org/10.4061/2011/827693
Research Article

Analysis of Nucleotide Variations in Genes of Iron Management in Patients of Parkinson's Disease and Other Movement Disorders

1Genomic Unit for the Diagnosis of Human Pathologies, Center for Genomics, Bioinformatics and Biostatistics, San Raffaele Scientific Institute, 20132 Milan, Italy
2Sezione di Chimica, Facoltà di Medicina, Università di Brescia & Terzo Laboratorio di Analisi Chimico Cliniche, Spedali Civili di Brescia, 25123 Brescia, Italy
3Centro Parkinson e Disturbi del Movimento, Istituti Clinici di Perfezionamento, 20126 Milan, Italy
4Centro della Microcitemia e Anemie Congenite, Ospedale Galliera, 16128 Genova, Italy
5Department of Clinical and Experimental Medicine, Section of Internal Medicine, University of Verona, 37134 Verona, Italy
6Università Vita-Salute San Raffaele, 20132 Milan, Italy
7Diagnostica e Ricerca San Raffaele SpA, Milan, Italy

Received 17 June 2010; Accepted 27 September 2010

Academic Editor: Carlo Colosimo

Copyright © 2011 Emanuela Castiglioni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. H. Koeppen, “The history of iron in the brain,” Journal of the Neurological Sciences, vol. 134, no. 1, pp. 1–9, 1995. View at Publisher · View at Google Scholar
  2. A. Friedman, J. Galazka-Friedman, and D. Koziorowski, “Iron as a cause of Parkinson disease—a myth or a well established hypothesis?” Parkinsonism and Related Disorders, vol. 15, supplement 3, pp. S212–S214, 2009. View at Publisher · View at Google Scholar
  3. L. Zecca, M. B. H. Youdim, P. Riederer, J. R. Connor, and R. R. Crichton, “Iron, brain ageing and neurodegenerative disorders,” Nature Reviews Neuroscience, vol. 5, no. 11, pp. 863–873, 2004. View at Publisher · View at Google Scholar · View at PubMed
  4. D. T. Dexter, A. Carayon, F. Javoy-Agid et al., “Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia,” Brain, vol. 114, no. 4, pp. 1953–1975, 1991. View at Google Scholar
  5. P. Riederer, E. Sofic, W.-D. Rausch et al., “Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains,” Journal of Neurochemistry, vol. 52, no. 2, pp. 515–520, 1989. View at Google Scholar
  6. E. Sofic, P. Riederer, H. Heinsen et al., “Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain,” Journal of Neural Transmission, vol. 74, no. 3, pp. 199–205, 1988. View at Google Scholar
  7. L. Zecca, A. Stroppolo, A. Gatti et al., “The role of iron and molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 26, pp. 9843–9848, 2004. View at Publisher · View at Google Scholar · View at PubMed
  8. D. Kaur, F. Yantiri, S. Rajagopalan et al., “Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease,” Neuron, vol. 37, no. 6, pp. 899–909, 2003. View at Publisher · View at Google Scholar
  9. A. Fredriksson, N. Schröder, P. Eriksson, I. Izquierdo, and T. Archer, “Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits,” Parkinsonism and Related Disorders, vol. 7, no. 2, pp. 97–105, 2001. View at Publisher · View at Google Scholar
  10. A. R. J. Curtis, C. Fey, C. M. Morris et al., “Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease,” Nature Genetics, vol. 28, no. 4, pp. 350–354, 2001. View at Publisher · View at Google Scholar · View at PubMed
  11. S. Levi, A. Cozzi, and P. Arosio, “Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation,” Best Practice and Research: Clinical Haematology, vol. 18, no. 2, pp. 265–276, 2005. View at Publisher · View at Google Scholar · View at PubMed
  12. X. Xu, S. Pin, M. Gathinji, R. Fuchs, and Z. L. Harris, “Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis,” Annals of the New York Academy of Sciences, vol. 1012, pp. 299–305, 2004. View at Publisher · View at Google Scholar
  13. T. A. Rouault and W. H. Tong, “Iron-sulfur cluster biogenesis and human disease,” Trends in Genetics, vol. 24, no. 8, pp. 398–407, 2008. View at Publisher · View at Google Scholar · View at PubMed
  14. T. LaVaute, S. Smith, S. Cooperman et al., “Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice,” Nature Genetics, vol. 27, no. 2, pp. 209–214, 2001. View at Publisher · View at Google Scholar · View at PubMed
  15. C. Borie, F. Gasparini, P. Verpillat et al., “Association study between iron-related genes polymorphisms and Parkinson's disease,” Journal of Neurology, vol. 249, no. 7, pp. 801–804, 2002. View at Publisher · View at Google Scholar · View at PubMed
  16. K. Thompson, S. Menzies, M. Muckenthaler et al., “Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress,” Journal of Neuroscience Research, vol. 71, no. 1, pp. 46–63, 2003. View at Publisher · View at Google Scholar · View at PubMed
  17. H. Hochstrasser, P. Bauer, U. Walter et al., “Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease,” Neurology, vol. 63, no. 10, pp. 1912–1917, 2004. View at Google Scholar
  18. C. Borie, F. Gasparini, P. Verpillat et al., “Association study between iron-related genes polymorphisms and Parkinson's disease,” Journal of Neurology, vol. 249, no. 7, pp. 801–804, 2002. View at Publisher · View at Google Scholar · View at PubMed
  19. P. Costa-Mallen, H. Checkoway, A. Zabeti et al., “The functional polymorphism of the hemoglobin-binding protein haptoglobin influences susceptibility to idiopathic Parkinson's disease,” American Journal of Medical Genetics Part B, vol. 147, no. 2, pp. 216–222, 2008. View at Publisher · View at Google Scholar · View at PubMed
  20. N. Akbas, H. Hochstrasser, J. Deplazes et al., “Screening for mutations of the HFE gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra,” Neuroscience Letters, vol. 407, no. 1, pp. 16–19, 2006. View at Publisher · View at Google Scholar · View at PubMed
  21. G. Biasiotto, S. Goldwurm, D. Finazzi et al., “HFE gene mutations in a population of Italian Parkinson's disease patients,” Parkinsonism and Related Disorders, vol. 14, no. 5, pp. 426–430, 2008. View at Publisher · View at Google Scholar · View at PubMed
  22. D. D. Buchanan, P. A. Silburn, J. B. Chalk, D. G. Le Couteur, and G. D. Mellick, “The Cys282Tyr polymorphism in the HFE gene in Australian Parkinson's disease patients,” Neuroscience Letters, vol. 327, no. 2, pp. 91–94, 2002. View at Publisher · View at Google Scholar
  23. M. C. J. Dekker, P. C. Giesbergen, O. T. Njajou et al., “Mutations in the hemochromatosis gene (HFE), Parkinson's disease and parkinsonism,” Neuroscience Letters, vol. 348, no. 2, pp. 117–119, 2003. View at Publisher · View at Google Scholar
  24. R. J. Guerreiro, J. M. Bras, I. Santana et al., “Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort,” BMC Neurology, vol. 6, article 24, 2006. View at Publisher · View at Google Scholar · View at PubMed
  25. A. J. Hughes, S. E. Daniel, L. Kilford, and A. J. Lees, “Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases,” Journal of Neurology Neurosurgery and Psychiatry, vol. 55, no. 3, pp. 181–184, 1992. View at Google Scholar
  26. A. J. Hughes, S. E. Daniel, and A. J. Lees, “Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease,” Neurology, vol. 57, no. 8, pp. 1497–1499, 2001. View at Google Scholar
  27. B. Foglieni, F. Ferrari, S. Goldwurm et al., “Analysis of ferritin genes in Parkinson disease,” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 11, pp. 1450–1456, 2007. View at Publisher · View at Google Scholar · View at PubMed
  28. E. Castiglioni, D. Finazzi, S. Goldwurm et al., “Sequence variations in mitochondrial ferritin: distribution in healthy controls and different types of patients,” Genet Test Mol Biomarkers, 2010. In press.
  29. N. Morello, E. Tonoli, F. Logrand et al., “Haemopexin affects iron distribution and ferritin expression in mouse brain,” Journal of Cellular and Molecular Medicine, vol. 13, pp. 4192–41204, 2009. View at Google Scholar